The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
$4.6m increase in cash (excluding one-offs), after paying off $10m worth of exceptional loans/bad contracts... sounds pretty good to me!
An initial $1.5m dividend would be a good start and a gesture to the future, but with those kinds of profits I can only see that value increasing.
Most importantly (for me), we ripe for a takeover now. There's clearly a few bad Chinese debtors, but the reduced cost of the London contract show that's already built in. For someone in the industry with the existing infrastructure they'd be able to take even higher profits by reducing the duplicated costs.
Finncap says 0.13p dividend. That makes it 1.6%yield returning 1.5m usd to start with. Not bad for a start and probably half again for interim
Pity no numbers but glad to see what we wanted. A few nice things in a trading update too. Now time for the last big top up and wait till March.
Amen Bonum!
We've been patient thus far and through the tremulous times, as Mozart played in the background and the share price was dragged theough the pits of investing Hell.
Now the exorcism of the demons that haunted the Company, both individuals and contracts, seem to be well vehind us as we move into the Light of Redemption.
As anticipated, some quick frolicking with profit taking from those suddenly released from the chains of the aforementioned Hell and into a world of break even.
However, many of us will be consistent with a view to the much larger gains we can reasonably anticipate going forward - both from a capital gains perspective and a dividend stream revenue.
Few are the AIM companies that can offer dividends, hence would certainly expect a raft of new retail investors & Institutions to enter the investment going forward.
Looking for the bigger rises & returns to come.....and finally the Takeover that we've anticipated for some time.
Atb all & have a divine day